Defence Therapeutics
Script error: No such module "AfC submission catcheck".
 | Some of this article's listed sources may not be reliable. (October 2021) (Learn how and when to remove this template message) |
| Public company | |
| Traded as | CSE: DTC |
| ISIN | 🆔CA24463V1013 |
| Industry | Biotechnology |
| Founded 📆 | 2017 |
| Founder 👔 | |
| Headquarters 🏙️ | Vancouver, Canada |
Area served 🗺️ | |
Key people | Sebastien Plouffe, CEO |
| Members | |
Number of employees | |
| 🌐 Website | www |
| 📇 Address | |
| 📞 telephone | |
Defence Therapeutics is a Canadian biotechnology company based in Vancouver. The company develops biologics and biosimilar antibody-based therapeutic drugs and vaccines for cancer and infectious diseases.
History[edit]
The company was founded in 2017 under the name Accum Therapeutics and renamed Defence Therapeutics in May 2020.[1] The company develops vaccines and therapies using patented platform technology named ACCUM and antibody drug conjugates (ADC) technology.[2]
Defence Therapeutics has a cancer vaccine in development. The cancer vaccine, Accuvac, was able to cure cancer in mice with a 70 percent success rate in a study announced in May 2021.[3]
The company is also developing a SARS-CoV-2 vaccine. This is expected to be protein-based and remain effective against a wide range of variants. According to a study announced May 31, 2021, a vaccine tested in animals successfully produced antibodies against all variants of SARS-CoV-2.[4]
References[edit]
- ↑ "Defence Therapeutics (CNSX:DTC) - Share price, News & Analysis". Simply Wall St. Retrieved 2021-07-09.
- ↑ "Accum Technology". Defence Therapeutics. Retrieved 2021-07-09.
- ↑ "Defence Therapeutics AccuVAC-D001 Cancer Vaccine Generates Effective Long-lasting Anti-Tumoral Response". Retrieved 2021-07-09.
- ↑ "The Antibody Response Induced by Defence Therapeutics AccuVAC-PT001 Vaccine Cross-Reacts with All Tested SARS-CoV-2 Variants". ca.finance.yahoo.com. Retrieved 2021-07-09.
This article "Defence Therapeutics" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Defence Therapeutics. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
